Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia

被引:54
作者
Altiok, O
Yasumatsu, R
Bingol-Karakoc, G
Riese, RJ
Stahlman, MT
Dwyer, W
Pierce, RA
Bromme, D
Weber, E
Cataltepe, S
机构
[1] Harvard Univ, Sch Med, Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA
[3] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN USA
[4] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN USA
[5] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA
[6] Univ British Columbia, Dept Oral & Biol Sci, Vancouver, BC V5Z 1M9, Canada
[7] Univ Halle Wittenberg, Inst Physiol Chem, Halle, Germany
关键词
baboon; bronchopulmonary dysplasia; cathepsin; macrophage; protease;
D O I
10.1164/rccm.200503-425OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Bronchopulmonary dysplasia (BPD) continues to be a major morbidity in preterm infants. The lung pathology in BIRD is characterized by impaired alveolar and capillary development. An imbalance between proteases and protease inhibitors in association with changes in lung elastic fibers has been implicated in the pathogenesis of BIRD. Objective: To investigate the expression and activity levels of papain-like lysosomal cysteine proteases, cathepsins B, H, K, L, S, and their inhibitors, cystatins B and C, in a baboon model of BPD. Methods: Real-time reverse transcriptase-polymerase chain reaction, immunohistochemistry, immunoblotting, active site labeling of cysteine proteases, and in situ hybridization were performed. Measurements and Main Results: The steady-state mRNA and protein levels of all cathepsins were significantly increased in the lung tissue of baboons with BPD. In contrast, the steady-state mRNA and protein levels of two major cysteine protease inhibitors, cystatin B and C, were unchanged. Correlating with these alterations, the activity of cysteine proteases in lung tissue homogenates and bronchoalveolar lavage fluid was significantly higher in the BPD group. The levels of cathepsin B, H, and S increased and cathepsin K decreased with advancing gestation. All cathepsins, except for cat K, were immunolocalized to macrophages in BIRD. In addition, cathepsin H and cystatin B were colocalized in type 2 alveolar epithelial cells. Cathepsin L was detected in some bronchial epithelial, endothelial, and interstitial cells. Cathepsin K was localized to some perivascular cells by in situ hybridization. Conclusions: Cumulatively, these findings demonstrate an imbalance between cysteine proteases and their inhibitors in BIRD.
引用
收藏
页码:318 / 326
页数:9
相关论文
共 56 条
[1]   Chronic lung injury in preterm lambs - Disordered respiratory tract development [J].
Albertine, KH ;
Jones, CP ;
Starcher, BC ;
Bohnsack, JF ;
Davis, PL ;
Cho, SC ;
Carlton, DP ;
Bland, RD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) :945-958
[2]  
ALTIOK O, 2005, P AM THORAC SOC, V2, pA24
[3]  
Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6
[4]  
BONIKOS DS, 1908, BRONCHOPULMONARY DYS, P33
[5]   Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes [J].
Brasch, F ;
ten Brinke, A ;
Johnen, G ;
Ochs, M ;
Kapp, N ;
Müller, KM ;
Beers, MF ;
Fehrenbach, H ;
Richter, J ;
Batenburg, JJ ;
Bühling, F .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 26 (06) :659-670
[6]   RISK-FACTORS FOR THE DEGRADATION OF LUNG ELASTIC FIBERS IN THE VENTILATED NEONATE - IMPLICATIONS FOR IMPAIRED LUNG DEVELOPMENT IN BRONCHOPULMONARY DYSPLASIA [J].
BRUCE, MC ;
SCHUYLER, M ;
MARTIN, RJ ;
STARCHER, BC ;
TOMASHEFSKI, JF ;
WEDIG, KE .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (01) :204-212
[7]   Pivotal role of cathepsin K in lung fibrosis [J].
Bühling, F ;
Röcken, C ;
Brasch, F ;
Hartig, R ;
Yasuda, Y ;
Saftig, P ;
Brömme, D ;
Welte, T .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (06) :2203-2216
[8]  
Bühling F, 1999, AM J RESP CELL MOL, V20, P612
[9]  
Bühling F, 2001, J PATHOL, V195, P375
[10]   Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2 [J].
Çataltepe, S ;
Schick, C ;
Luke, CJ ;
Pak, SCO ;
Goldfarb, D ;
Chen, P ;
Tanasiyevic, MJ ;
Posner, MR ;
Silverman, GA .
CLINICA CHIMICA ACTA, 2000, 295 (1-2) :107-127